WEEKLY MITOMYCIN C FOLLOWED BY MONTHLY BACILLUS CALMETTE-GUERIN OR ALTERNATING MONTHLY INTERFERON-α2B AND BACILLUS CALMETTE-GUERIN FOR PROPHYLAXIS OF RECURRENT PAPILLARY SUPERFICIAL BLADDER CARCINOMA-Reference-Cited by-同舟云学术

WEEKLY MITOMYCIN C FOLLOWED BY MONTHLY BACILLUS CALMETTE-GUERIN OR ALTERNATING MONTHLY INTERFERON-α2B AND BACILLUS CALMETTE-GUERIN FOR PROPHYLAXIS OF RECURRENT PAPILLARY SUPERFICIAL BLADDER CARCINOMA

Published:2000-07 Issue:1 Volume:164 Page:47-52
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KAASINEN EERO¹,RINTALA ERKKI¹,PERE ANNA-KAISA¹,KALLIO JUKKA¹,PUOLAKKA VELI-MATTI¹,LIUKKONEN TAPANI¹,TUHKANEN KARI¹,

Affiliation:

1. From the Hyvinkää Hospital, Hyvinkää, Helsinki City Hospital and Helsinki University Central Hospital, Helsinki, Tampere University Hospital, Tampere, South Karelian Central Hospital, Lappeenranta, Mikkeli Central Hospital, Mikkeli and Kuopio University Hospital, Kuopio, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Superficial bladder cancer: the role of interferon-α;Belldegrun;J Urol,1998

2. A randomized study of intravesical Mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder;Vegt;J Urol,1995

3. Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer;Witjes;Urology,1998

4. BCG in perspective: advances in the treatment of superficial bladder cancer;Lamm;Eur Urol,1995

5. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer;Cochrane Database of Systematic Reviews;2020-01-08

2. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment;Oncology Reports;2019-01-10

3. Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer;Scientific Reports;2017-06-09

4. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer;Cochrane Database of Systematic Reviews;2017-03-08

5. Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study;European Urology;2015-10